Article Type

106 - 120 of 256 Results       Clear All

SF Team Seeks COVID-19 Therapies and Ways to Defeat Future Coronaviruses

Gladstone in the News March 4, 2021

SF Team Seeks COVID-19 Therapies and Ways to Defeat Future Coronaviruses

San Francisco Public Press—Senior Investigator Warner Greene describes the efforts of Gladstone scientists to discover ways to treat the acute and long-term consequences of COVID-19, and their hope of discovering antiviral approaches that could be ready for use to battle future pandemic viruses.

Gladstone Experts COVID-19 Infectious Disease Greene Lab

Coronavirus Variants Will Prolong the Pandemic. But Here’s How It Could End

Gladstone in the News January 24, 2021

Coronavirus Variants Will Prolong the Pandemic. But Here’s How It Could End

San Francisco Chronicle—The United States is trying accelerate coronavirus vaccine distribution, which could allow the country to achieve herd immunity. However, Gladstone virologist Warner Greene points out that the coronavirus is a global problem, and ending the pandemic will require mobilizing vaccines around the world.

Gladstone Experts COVID-19 Infectious Disease Greene Lab

The Coronavirus Is Changing Faster Than Scientists Thought. Can Vaccines Still Stamp It Out?

Gladstone in the News January 20, 2021

The Coronavirus Is Changing Faster Than Scientists Thought. Can Vaccines Still Stamp It Out?

San Francisco Chronicle—New coronavirus variants are emerging around the world, including in the Bay Area. Melanie Ott, director of the Gladstone Institute of Virology, explains that if the vaccine rollout isn’t fast enough, viral variants that can evade the vaccine may become prevalent, rendering the vaccine partially ineffective.

Gladstone Experts COVID-19 Infectious Disease Ott Lab

Bay Area Researchers Develop New Rapid COVID-19 Test That Uses Smartphone Camera

Gladstone in the News January 15, 2021

Bay Area Researchers Develop New Rapid COVID-19 Test That Uses Smartphone Camera

ABC7 News—Gladstone Institute of Virology Director Melanie Ott, MD, PhD, and Graduate Student Parinaz Fozouni comment on the COVID-19 detection test they recently developed with Nobel Laureate Jennifer Doudna, PhD, and UC Berkeley Professor Dan Fletcher, PhD, using CRISPR and smartphone technology.

Gladstone Experts COVID-19 Infectious Disease Doudna Lab Ott Lab CRISPR/Gene Editing

Can CRISPR-Based COVID-19 Testing Using Smartphones Slow the Pandemic?

Gladstone in the News December 13, 2020

Can CRISPR-Based COVID-19 Testing Using Smartphones Slow the Pandemic?

Forbes—In an article about the need for rapid testing to monitor and curb the COVID-19 pandemic, Melanie Ott, MD, PhD, director of the Gladstone Institute of Virology, explains the advantages of the CRISPR- and smartphone-based detection platform she developed with Senior Investigator and Nobel Laureate Jennifer Doudna, PhD, and UC Berkeley Professor Dan Fletcher, PhD.

Gladstone Experts COVID-19 Data Science and Biotechnology Infectious Disease Doudna Lab Ott Lab

COVID Test May Be as Close as Your Smartphone, Say UC, Gladstone Researchers

Gladstone in the News December 11, 2020

COVID Test May Be as Close as Your Smartphone, Say UC, Gladstone Researchers

San Francisco Business Times—Melanie Ott, MD, PhD, director of the Gladstone Institute of Virology, discusses the rapid, smartphone-based Coronavirus detection assay her group recently described in the scientific publication Cell. The assay was developed by Graduate Student Parinaz Fozouni, in collaboration with the labs of Senior Scientist and Nobel Laureate Jennifer Doudna, PhD, and of UC Berkeley Bioengineering Professor Dan Fletcher, PhD.

Gladstone Experts COVID-19 Data Science and Biotechnology Infectious Disease Doudna Lab Ott Lab

Does COVID-19 Result in Lasting Immunity? Growing Evidence Says Yes

Gladstone in the News November 17, 2020

Does COVID-19 Result in Lasting Immunity? Growing Evidence Says Yes

San Francisco Chronicle—Associate Investigator Nadia Roan, PhD, comments on recent findings by her group and others that COVID-19 patients retain immune cells against the new coronavirus for several months after infection, which bodes well for the ability of vaccines to provide lasting protection against the disease.

Gladstone Experts COVID-19 Infectious Disease Roan Lab

More News

Are You a Journalist Looking to Write about Gladstone?

Explore Info for Media